Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
Potassium salts of aralkylphosphonosulfonic acids are prepared as inhibitors of dehydrosqualene synthase (CrtM) in order to inhibit the biosynthesis of the Staphylococcus aureus virulence factor staphyloxanthin.